Moderna expects to have cancer and heart disease vaccines ready by the end of the decadeProactive Investors • 04/11/23
Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030CNBC • 04/10/23
Moderna Surges On A Key Win For Its Merck-Partnered Cancer Vaccine In EuropeInvestors Business Daily • 04/10/23
MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV MelanAccesswire • 04/06/23
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It OutInvestors Business Daily • 03/31/23
Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing FacilityAccesswire • 03/30/23
Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic ResolutionBusiness Wire • 03/30/23
Moderna CEO draws Bernie Sanders' ire over plans to raise vaccine price 5x for consumer marketsProactive Investors • 03/23/23
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic MedicinesAccesswire • 03/23/23
Moderna CEO Stephane Bancel defends fivefold price hike of Covid vaccine during Senate grillingCNBC • 03/22/23